Clinical Trials Browser

Neoplasms, Plasma Cell × poly ICLC × 90 days × Clear all

NCT02886065 2026-03-13

A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM

Phase 1 Active not recruiting

Smoldering Multiple Myeloma, Neoplasms, Plasma Cell